Tong Ren Tang | Briefing, News, Analysis, Research, Data

Tong Ren Tang

Tong Ren Tang specalized in traditional Chinese medicine and therapy.

Tong Ren Tang, founded in 1669 and headquartered in Beijing, is a leading Chinese pharmaceutical company. As a subsidiary of Beijing TRT Group, the company was listed on the Shanghai Stock Exchange in 1997. Rivals with direct and indirect competition include Pientzehuang Pharmaceutical, Yunan Baiyao, and Dong-E-E-Jiao.

Sector

Healthcare

Industry

General Healthcare

Sub-industry

Founded

Jul 1, 1992

HQ location

Beijing, China

Legal name

Beijing Tong Ren Tang Co., Ltd.

Website

http://www.tongrentang.com/

jtjlb@tongrentang.com

Employees

18398

All
News
Analysis
Research

Briefing Sep 26, 2022 09:27 PM · Healthcare

Intracardiac Echocardiography Enterprise, Cardioacc, Wins Angel Round Financing

Briefing Jun 28, 2022 04:29 PM · Healthcare

Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction

In-depth

Time-honored Chinese medicine brands: how far can they go? Image credit: Leon Gan/Unsplash

Healthcare

Tong Ren Tang: Any Hope for this Purveyor of Centuries-Old Chinese Medicines?

Since the biotechnology pharmaceutical scene has become a red ocean, attracting new entrants and capital, TCM players are encountering some harsh new realities.

Jul 22, 2020 11:53 AM

Briefing Jun 28, 2022 10:08 AM · Healthcare

Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy

Briefing Jun 28, 2022 09:57 AM · Healthcare

Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China

Research

Healthcare

Digital Therapeutics - Revolution of the healthcare system

Nov 16, 2022 05:19 PM

Research

Healthcare

2022 China AI Health 30 Report

Nov 07, 2022 04:27 PM

Research

Healthcare

2022 China’s Healthcare Industry: An Introductory Handbook

Aug 29, 2022 05:45 PM

Research

Healthcare

China's Aesthetic Medicine Body Contouring Industry

Apr 18, 2022 06:30 PM

Briefing Jun 24, 2022 11:15 AM · Healthcare

F-star to be acquired by China biopharmaceutical with USD 161million

Briefing Jun 24, 2022 11:07 AM · Healthcare

"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange

Briefing Jun 24, 2022 10:59 AM · Technology | Healthcare

Herui gene launched the early screening product "quansining" for multiple cancer types, covering six high-risk cancer types

Briefing Jun 24, 2022 10:46 AM · Healthcare

East China medicine "liraglutide" goes to sea

Healthcare

Lanja has completed the Series A funding of hundred millions CNY

Shanghai Lanja Medical Technology Co., Ltd (“Lanja”) recently has announced the completion of the Series A funding of hundred millions CNY.

Sep 11, 2023 10:04 PM

Healthcare

RabPharma has completed the Series A+ funding of hundred millions CNY

Zhongshan RabPharma Biopharmaceutical Co., Ltd. (“RabPharma”) recently has announced the completion of the Series A+ funding of hundred millions CNY.

Sep 05, 2023 10:17 AM

Briefing Jun 22, 2022 06:49 PM · Technology | Healthcare

Energy saving Tiehan: the consortium is expected to win the bid for the 243million yuan sewage treatment construction project

Briefing Jan 11, 2022 02:48 PM · Consumer Staples | Industrials | Financials

At present, there are more than 328000 container related enterprises in China, accounting for 30% in Shandong Province and Guangdong Province

Briefing Jan 06, 2022 04:09 PM · Technology | Consumer Staples | Healthcare

New Beiyang: the subsidiary won the bid for the procurement project of China Post super teller machine

In-depth

The herb has been used for thousands of years. Image credit: Annie Spratt/Unsplash

Healthcare

Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)

Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.

May 19, 2020 12:30 PM

In-depth